The Changing Faces of Beauty:

A Global Report 2016

  • A report by Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma, has revealed women’s attitudes to beauty across the globe.
  • The Changing Faces of Beauty: A Global Report 2016 was commissioned by Allergan and conducted by Insight Engineers via an online questionnaire, surveying 7,700 “aesthetically aware” female respondents from 16 countries including the UK
  • Fieldwork undertaken by Insight Engineers according to strict market research guidelines took place in March 2016 with ‘aesthetically aware’ women aged 18-65.
  • Online interviews with 7,700 women were conducted in the following countries: Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Mexico, Netherlands, South Korea, Spain, Thailand, Turkey, UK and the US


View & Download Here


  • 500 interviews were undertaken in each country apart from those with less active online female populations (Mexico, South Korea and Turkey), where 400 interviews per country were conducted
  • Results showed that 74% of women make an effort to look good for themselves while 37% do so for their partners.
  • 56% of women interviewed rank “skin quality” as their number-one beauty priority and as equally important as body shape and figure. When describing female beauty, 23% of respondents used words that describe skin such as complexion, glowing, smooth and flawless.
  • “Skin quality has always been a concern and is becoming increasingly important to women across the world… the search for a smooth and youthful skin quality remains a constant across countries,” said plastic surgeon Dr Mauricio de Maio, who worked on the report. 
  • Two thirds said under eye bags (66%) were their number-one skin concern, followed closely by double chins (60%), loss of fullness in cheeks (52%) and volume in the lips (43%). As a result, 21% said double chins affect their confidence and make them look and feel older.
  • “Bags under the eyes and dark circles are universal concerns for women,” said cosmetic surgeon Dr Jonquille Chantrey, who also worked on the report. “The darker discolouration under the eye can really impact the quality of the complexion.”
  • 81% are committed to a regular facial skincare routine, with Thai (96%), Chinese (89%) and Spanish (88%) women leading the way. The report also found that Chinese women spend an average of €80 (£67) a month on beauty products compared to Brits who only spend €25 (£21).
  • The evolution of the aesthetic market means women are now faced with a wider range of options to treat their beauty concerns. For example, 42% said they would consider a treatment with injectables as a way to boost their self-confidence while the same amount of respondents said they would to improve the aesthetics of sagging skin, the report found.  
  • Crucially 65% of women believe that facial fillers have become more socially acceptable compared to five years ago and 57% of women said they believe facial fillers can look natural.

About Allergan

Allergan is focused on developing, manufacturing and commercialising innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.

  • Allergan markets a portfolio of high quality products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women’s health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world’s third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry and a leading position in the submission of generic product applications globally.
  • With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.